Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia

Published:2024-08-15 Issue:9 Volume:7 Page:2840-2855
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Nasrullah Mohammad¹²^ORCID,KC Remant²^ORCID,Nickel Kyle²,Parent Kylie²,Kucharski Cezary²,Meenakshi Sundaram Daniel Nisakar²,Rajendran Amarnath Praphakar²,Jiang Xiaoyan³,Brandwein Joseph⁴,Uludağ Hasan¹²^ORCID

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2H1, Canada

2. Department of Chemical and Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta T6G 1R1, Canada

3. Terry Fox Laboratory, British Colombia Cancer Research Institute and Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada

4. Division of Hematology, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta T6G 2R7, Canada

Funder

Canadian Institutes of Health Research

Edmonton Civic Employees Charitable Assistance Fund

University of Alberta

Alex's Lemonade Stand Foundation for Childhood Cancer

Natural Sciences and Engineering Research Council of Canada

Mitacs

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.4c00336

Reference74 articles.

1. Therapeutic siRNA: state of the art

2. Where should siRNAs go: applicable organs for siRNA drugs

3. RNA interference in the era of nucleic acid therapeutics

4. Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein

5. Peripheral Blood Mononuclear Cells